Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin Open-Label Extension in Chronic Neuropathic Pain
NCT00141362Phase 3Completed
- Sponsor
- Pfizer
- Start
- Oct 2001
- Modality
- Small Molecules
01
Overview
Phase 3, open-label, single-arm trial of pregabalin in diabetic neuropathy and postherpetic neuralgia (PHN), sponsored by Pfizer. Primary endpoint: Safety and efficacy. Started Oct 2001; status: completed.
02
Drugs
pregabalin
03
Conditions
diabetic neuropathypostherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT00141362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00141362.